Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series
Lingyu Tan, Guozhen Yang, Chufeng Zeng, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages
Da-Long Yang, Lin Ye, Fan-Jian Zeng, et al.
Hepatology (2025)
Closed Access
Local-region treatment comparison following conversion therapy of hepatocellular carcinoma: a period and age-dependent analysis
Jiahui Hu, Shu Zhao, Mengxuan Zuo, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Treatment for Unresectable Hepatocellular Carcinoma Patients: Options and Management after Complete Response
Jinming Wang, Guangle Qiu, Zhidong Liu, et al.
iLiver (2025), pp. 100145-100145
Open Access
A bibliometric and visual analysis based on immune checkpoint inhibitors for hepatocellular carcinoma: 2014 – 2024
Gao‐Min Liu, Rui Guo, Jiwei Xu
Frontiers in Pharmacology (2025) Vol. 16
Open Access
De-escalated surgery following neoadjuvant chemoimmunotherapy for locally advanced oral squamous cell carcinoma: A retrospective cohort study
Fei Cao, Qi Fang, Ruobin Lin, et al.
Oral Oncology (2025) Vol. 165, pp. 107348-107348
Closed Access
Impact of neoadjuvant multimodal therapy in the setting of locally advanced hepatocellular carcinoma
Daniele Ferraro, Federica Falaschi, Luca Nazzaro, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 28, pp. 3452-3455
Open Access | Times Cited: 1
Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced HCC
Zhenyun Yang, Qianyu Wang, Hu Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition)
Haowen Tang, Wenwen Zhang, Junning Cao, et al.
BioScience Trends (2024) Vol. 18, Iss. 6, pp. 505-524
Open Access | Times Cited: 1
Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced hepatocellular carcinoma
Zhenyun Yang, Qianyu Wang, Hu Li, et al.
Research Square (Research Square) (2024)
Open Access
Comparing Watch-and-Wait vs. resection in radiologic complete response after conversion therapy for unresectable hepatocellular carcinoma: Correspondence
Long Luo, Yao Liu, Ling Zhu
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 10, pp. 6350-6351
Open Access
Prognosis predictors of hepatocellular carcinoma after hepatectomy following conversion therapy
Shaoru Liu, Zongfeng Wu, Chenwei Wang, et al.
European Journal of Surgical Oncology (2024) Vol. 51, Iss. 1, pp. 109375-109375
Closed Access
A commentary on “Comparison of survival benefit and safety between surgery following conversion therapy versus surgery alone in patients with surgically resectable hepatocellular carcinoma at CNLC IIb/IIIa stage: a propensity score matching study”
Jia Luo, Qian Yang, Wen Ma, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 9, pp. 6045-6046
Open Access
Case report: Complete response after transcatheter arterial chemoembolization combined with donafenib plus tislelizumab therapy for hepatocellular carcinoma with main trunk portal vein tumor thrombus in a patient coinfected with HIV and HBV
Xuhua Xiao, Haixiao Fu, Huixia Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Non-surgery strategy versus hepatectomy in hepatocellular carcinoma patients with complete response after conversion therapy: a meta-analysis
Jie Wang, Yanfeng Hu, Lingyi Zhou, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access
Page 1

Scroll to top